Prevalence and risk factors for opportunistic infections in HIV patients who developed adverse drug reactions (ADRs) to antiretroviral therapy (ART) in a tertiary-care teaching hospital

Kolar Bylappa Bhuvana; Narasimhe Gowda Hema; Rajesh T Patil

doi:10.5455/njppp.2015.5.0301201517

2022, Vol: 12, Issue: 6

12/6Current Issue Online First Archive Aims and Scope Abstracting & Indexing Most Accessed Articles Most Downloaded Articles Most Cited Articles

Required files to be uploaded

Authorship Declaration

« Previous Article

Original Research

Natl J Physiol Pharm Pharmacol. 2015; 5(3): 200-206

doi: 10.5455/njppp.2015.5.0301201517

Prevalence and risk factors for opportunistic infections in HIV patients who developed adverse drug reactions (ADRs) to antiretroviral therapy (ART) in a tertiary-care teaching hospital

Kolar Bylappa Bhuvana, Narasimhe Gowda Hema, Rajesh T Patil.

Cited by (3)

Abstract
Background: The introduction of highly active antiretroviral therapy (HAART) has led to decline in HIV-related opportunistic infections (OIs). Knowledge of the most common OI of that geographical area will help in implementing the preventive measures against that pathogen. We determined the prevalence and risk factors for OIs among patients who developed adverse drug reaction (ADR) to antiretroviral therapy (ART) in a tertiary-care teaching hospital.

Aims and Objective: To collect demographic details of HIV-positive patients who were on ART and developed ADR to ART with OI and without OI; to determine the prevalence of OIs in HIV-positive patients who developed ADR to ART; and to investigate the sociodemographic and clinical risk factors associated with their occurrence.

Materials and Methods: A cross-sectional study carried out between January and June 2012. The study population comprised HIV-infected patients, who were receiving ART at ART Center, KR Hospital of Mysore Medical College and Research Institute, Mysore, Karnataka, India, who developed ADRs to ART with or without OI.

Results: The prevalence of OI was 50.63%. The sociodemographic variables that had significant positive association with the presence of OIs on univariate analysis includes employment [odds ratio (OR) = 4.96, 95% confidence interval (CI) = 2.529.75; p = 0.00). The risk of OIs did not significantly differ according to gender (OR = 0.77, 95% CI = 0.411.45; p = 0.21), age (OR = 1.658, 95% CI = 0.823.32; p = 0.079), residence (OR = 0.812, 95% CI = 0.431.52; p = 0.26), literacy (OR = 0.90, 95% CI = 0.481.70; p = 0.38), marital status (OR = 1.8, 95% CI = 0.704.61; p = 0.11), or weight (OR = 1.69, 95% CI = 0.843.42; p = 0.07). The univariate analysis of clinical risk factors for OIs had a significant positive association with WHO staging (OR = 24.04, 95% CI = 5.5105.01; p = 0.00) and CD4 count (OR = 2.61, 95% CI = 1.325.16; p = 0.00). The risk of OIs did not significantly differ with adherence (OR = 0.37, 95% CI = 0.071.99; p = 0.13).

Conclusion: OIs remain a challenge in patients receiving ART in resource-limited settings. There is a need to intensify the management of OIs despite ART use.

Key words: Adverse drug reactions, Antiretroviral therapy, Opportunistic infections, Prevalence, Risk factors.

	ARTICLE TOOLS
	Abstract
	PDF Fulltext
	How to cite this article
	Citation Tools
	Related Records
	Articles by Kolar Bylappa Bhuvana Articles by Narasimhe Gowda Hema Articles by Rajesh T Patil
	on Google
	on Google Scholar

REFERENCES

1. NACO, Department of AIDS Control, National AIDS Control Organization, Ministry of Health & Family Welfare, Government of India.

2. Kaplan JE, Benson C, Holmes KK, Brooks JT, Pau A, Masur H; Centers for Disease Control and Prevention (CDC); National Institutes of Health; HIV Medicine Association of the Infectious Diseases Society of America. Guidelines for prevention and treatment of opportunistic infections in HIV-infected adults and adolescents: recommendations from CDC, the National Institutes of Health, and the HIV Medicine Association of the Infectious Diseases Society of America. MMWR Recomm Rep. 2009;58(RR-4): 1-207; quiz CE1-4.

3. Chaisson RE, Gallant JE, Keruly JC, Moore RD. Impact of opportunistic disease on survival in patients with HIV infection. AIDS. 1998;12:29-33. [DOI via Crossref] [Pubmed]

4. Moore RD, Chaisson RE. Natural history of opportunistic disease in an HIV-infected urban clinical cohort. Ann Intern Med. 1996; 124:633-42. [DOI via Crossref]

5. Finkelstein DM, Williams PL, Molenberghs G, Feinberg J, Powderly WG, Kahn J, et al. Patterns of opportunistic infections in patients with HIV infection. J Acquir Immune Defic Syndr Hum Retrovirol. 1996;12:38-45. [DOI via Crossref] [Pubmed]

6. Chaisson RE, Moore RD. Prevention of opportunistic infections in the era of improved antiretroviral therapy. J Acquir Immune Defic Syndr Hum Retrovirol. 1997;16:S14-22. [DOI via Crossref] [Pubmed]

7. Glesby MJ, Hoover DR, Farzadegan H, Margolick JB, Saah AJ. The effect of influenza vaccination on human immunodeficiency virus type 1 load: a randomized, double-blind, placebo-controlled study. J Infect Dis. 1996;174:1332-6. [DOI via Crossref] [Pubmed]

8. Palacios R, JimÃ©nez-O-ate F, Aguilar M, Galindo MJ, Rivas P, et al. Impact of syphilis infection on HIV viral load and CD4 cell counts in HIV-infected patients. J Acquir Immune Defic Syndr. 2007;44:356-9. [DOI via Crossref] [Pubmed]

9. Bentwich Z, Maartens G, Torten D, Lal AA, Lal RB. Concurrent infections and HIV pathogenesis. AIDS. 2000;14:2071-81. [DOI via Crossref] [Pubmed]

10. Sulkowski MS, Chaisson RE, Karp CL, Moore RD, Margolick JB, et al. The effect of acute infections illnesses on plasma human immunodeficiency virus (HIV) type 1 load and the expression of serologic markers of immune activation among HIV-infected adults. J Infect Dis. 1998;178:1642-8. [DOI via Crossref] [Pubmed]

11. Donovan RM, Bush CE, Markowitz NP, Baxa DM, Saravolatz LD. Changes in virus load markers during AIDS-associated opportunistic diseases in human immunodeficiency virus-infected persons. J Infect Dis. 1996;174:401-3. [DOI via Crossref] [Pubmed]

12. dÂArminio Monforte A, Lepri AC, Rezza G, Pezzoti P, Antinori A, Phillips AN, et al. Insights into the reasons for discontinuation of the firstly highly active anti retro viral therapy (HAART) regimen in a cohort of antiretroviral naÃ¯ve patients: Italian cohort of antiretroviral naÃ¯ve patients. AIDS. 2000;14:499-507. [DOI via Crossref]

13. Ledergerber B, Egger M, Erard V, Weber R, Hirschel B, Furrer H, et al. AIDS related opportunistic illnesses occurring after initiation of potent antiretroviral therapy: the Swiss HIV Cohort Study. JAMA. 1999;282:2220-6. [DOI via Crossref] [Pubmed]

14. Ives NJ, Gazzard BG, Easterbrook PJ. The changing pattern of AIDS-defining illnesses with the introduction of highly active antiretroviral therapy (HAART) in a London clinic. J Infect. 2001;42: 134-9. [DOI via Crossref] [Pubmed]

15. Seyler C, Messou E, Gabillard D, Inwoley A, Alioum A, Anglaret X. Morbidity before and after HAART initiation in Sub-Saharan African HIV-infected adults: a recurrent event analysis. AIDS Res Hum Retroviruses. 2007;23:1338-47. [DOI via Crossref] [Pubmed]

16. Moges NA, Kassa GM. Prevalence of opportunistic infections and associated factors among HIV positive patients taking anti-retroviral therapy in DebreMarkos Referral Hospital, Northwest Ethiopia. J AIDS Clin Res. 2014;5:301. [DOI via Crossref]

17. Sun HY, Chen MY, Hsieh SM, Sheng WH, Chang SY, et al. Changes in the clinical spectrum of opportunistic illnesses in persons with HIV infection in Taiwan in the era of highly active antiretroviral therapy. Jpn J Infect Dis. 2006;59:311-6. [Pubmed]

18. Mzileni MO, Longo-Mbenza B, Chephe TJ. Mortality and causes of death in HIV-positive patients receiving antiretroviral therapy at Tshepang Clinic in Doctor George Mukhari Hospital. Pol Arch Med Wewn. 2008;118:548-54. [Pubmed]

19. Iroezindu MO, Ofondu EO, Hausler H, van Wyk B. Prevalence and risk factors for opportunistic infections in HIV patients receiving antiretroviral therapy in a resource-limited setting in Nigeria. J AIDS Clin Res. 2013;S3:002.

20. Damtie D, Yismaw G, Woldeyohannes D, Anagaw B. Common opportunistic infections and their CD4 cell correlates among HIVinfected patients attending at antiretroviral therapy clinic of Gondar University Hospital, Northwest Ethiopia. BMC Res Notes. 2013;6:534. [DOI via Crossref] [Pubmed] [PMC Free Fulltext]

21. Goud TG, Ramesh K. Opportunistic infections among HIV patients attending tertiary care hospital, Karnataka, India. Int J Curr Microbiol Appl Sci. 2014;3(4):824-9.

22. Ghate M, Deshpande S, Tripathy S, Nene M, Gedam P, Godbole S, et al. Incidence of common opportunistic infections in HIV-infected individuals in Pune, India: analysis by stages of immunosuppression represented by CD4 counts. Int J Infect Dis. 2009;13:e1-8. [DOI via Crossref] [Pubmed]

23. Gautam L, Deshpande JD, Somasundaram KV. Prevalence of HIV-TB co-infection, clinical profile and CD4 count of HIV patients attending ART centre of Ahmednagar, Maharashtra. Int J Med Sci Public Health. 2014;3:1105-9. [DOI via Crossref]

24. Saha K, Firdaus R, Santra P, Pal J, Roy A, Bhattacharya MK, et al. Recent pattern of co-infection amongst HIV seropositive individuals in tertiary care hospital, Kolkata. Virol J. 2011;8:116. [DOI via Crossref] [Pubmed] [PMC Free Fulltext]

25. Elizabeth ST, Kiran N. Prevalence of opportunistic infections and its treatment in patients with HIV infection in a south Indian tertiary care hospital. Indian J Pharm Pract. 2013;6(3):28-31.

26. Shahapur PR, Bidri RC. Recent trends in the spectrum of opportunistic infections in human immunodeficiency virus infected individuals on antiretroviral therapy in South India. J Nat Sci Biol Med. 2014;5:392-6. [DOI via Crossref] [Pubmed] [PMC Free Fulltext]

27. Palella FJ Jr, Delaney KM, Moorman AC, Loveless MO, Fuhrer J, et al. Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators. N Engl J Med. 1998;338:853-60. [DOI via Crossref] [Pubmed]

28. Lawn SD, Badri M, Wood R. Tuberculosis among HIV-infected patients receiving HAART: long term incidence and risk factors in a South African cohort. AIDS. 2005;19:2109-16. [DOI via Crossref] [Pubmed]

29. Komati S, Shaw PA, Stubbs N, Mathibedi MJ, Malan L, Sangweni P, et al. Tuberculosis risk factors and mortality for HIV-infected persons receiving antiretroviral therapy in South Africa. AIDS. 2010;24:1849-55. [DOI via Crossref] [Pubmed] [PMC Free Fulltext]

30. Corey DM, Kim HW, Salazar R, Illescas R, Villena J, Gutierrez L, et al. Brief report: effectiveness of combination antiretroviral therapy on survival and opportunistic infections in a developing world setting: an observational cohort study. J Acquir Immune Defic Syndr. 2007;44:451-5. [DOI via Crossref] [Pubmed]

31. Manosuthi W, Chaovavanich A, Tansuphaswadikul S, Prasithsirikul W, Inthong Y, Chottanapund S, et al. Incidence and risk factors of major opportunistic infections after initiation of antiretroviral therapy among advanced HIV-infected patients in a resourcelimited setting. J Infect. 2007;55:464-9. [DOI via Crossref] [Pubmed]

32. Srirangaraj S, Venkatesha D. Opportunistic infections in relation to antiretroviral status among AIDS patients from south India. Indian J Med Microbiol. 2011;29:395-400. [DOI via Crossref] [Pubmed]

33. Kaplan JE, Hanson D, Dworkin MS, Frederick T, Bertolli J, Lindegren ML, et al. Epidemiology of human immunodeficiency virusassociated opportunistic infections in the United States in the era of highly active antiretroviral therapy. Clin Infect Dis. 2000; 30:5-14. [DOI via Crossref] [Pubmed]

This Article Cited By the following articles

Incidence of Pneumonia and Predictors Among Human Immunodeficiency Virus Infected Children at Public Health Institutions in the Northwest Part of Ethiopia: Multicenter Retrospective Follow-Up Study PHMT 2022; Volume 13(): 13.	1

Incidence of common opportunistic infections among HIV-infected children on ART at Debre Markos referral hospital, Northwest Ethiopia: a retrospective cohort study BMC Infect Dis 2020; 20(1): .	2

Determinants of Active Tuberculosis Occurrences after ART Initiation among Adult HIV-Positive Clients in West Showa Zone Public Hospitals, Ethiopia: A Case-Control Study Advances in Public Health 2020; 2020(): 1.	3

How to Cite this Article

Pubmed Style

Kolar Bylappa Bhuvana, Narasimhe Gowda Hema, Rajesh T Patil. Prevalence and risk factors for opportunistic infections in HIV patients who developed adverse drug reactions (ADRs) to antiretroviral therapy (ART) in a tertiary-care teaching hospital. Natl J Physiol Pharm Pharmacol. 2015; 5(3): 200-206. doi:10.5455/njppp.2015.5.0301201517

Web Style

Kolar Bylappa Bhuvana, Narasimhe Gowda Hema, Rajesh T Patil. Prevalence and risk factors for opportunistic infections in HIV patients who developed adverse drug reactions (ADRs) to antiretroviral therapy (ART) in a tertiary-care teaching hospital. https://www.njppp.com/?mno=176681 [Access: June 02, 2022]. doi:10.5455/njppp.2015.5.0301201517

AMA (American Medical Association) Style

Kolar Bylappa Bhuvana, Narasimhe Gowda Hema, Rajesh T Patil. Prevalence and risk factors for opportunistic infections in HIV patients who developed adverse drug reactions (ADRs) to antiretroviral therapy (ART) in a tertiary-care teaching hospital. Natl J Physiol Pharm Pharmacol. 2015; 5(3): 200-206. doi:10.5455/njppp.2015.5.0301201517

Vancouver/ICMJE Style

Kolar Bylappa Bhuvana, Narasimhe Gowda Hema, Rajesh T Patil. Prevalence and risk factors for opportunistic infections in HIV patients who developed adverse drug reactions (ADRs) to antiretroviral therapy (ART) in a tertiary-care teaching hospital. Natl J Physiol Pharm Pharmacol. (2015), [cited June 02, 2022]; 5(3): 200-206. doi:10.5455/njppp.2015.5.0301201517

Harvard Style

Kolar Bylappa Bhuvana, Narasimhe Gowda Hema, Rajesh T Patil (2015) Prevalence and risk factors for opportunistic infections in HIV patients who developed adverse drug reactions (ADRs) to antiretroviral therapy (ART) in a tertiary-care teaching hospital. Natl J Physiol Pharm Pharmacol, 5 (3), 200-206. doi:10.5455/njppp.2015.5.0301201517

Turabian Style

Kolar Bylappa Bhuvana, Narasimhe Gowda Hema, Rajesh T Patil. 2015. Prevalence and risk factors for opportunistic infections in HIV patients who developed adverse drug reactions (ADRs) to antiretroviral therapy (ART) in a tertiary-care teaching hospital. National Journal of Physiology, Pharmacy and Pharmacology, 5 (3), 200-206. doi:10.5455/njppp.2015.5.0301201517

Chicago Style

Kolar Bylappa Bhuvana, Narasimhe Gowda Hema, Rajesh T Patil. "Prevalence and risk factors for opportunistic infections in HIV patients who developed adverse drug reactions (ADRs) to antiretroviral therapy (ART) in a tertiary-care teaching hospital." National Journal of Physiology, Pharmacy and Pharmacology 5 (2015), 200-206. doi:10.5455/njppp.2015.5.0301201517

MLA (The Modern Language Association) Style

Kolar Bylappa Bhuvana, Narasimhe Gowda Hema, Rajesh T Patil. "Prevalence and risk factors for opportunistic infections in HIV patients who developed adverse drug reactions (ADRs) to antiretroviral therapy (ART) in a tertiary-care teaching hospital." National Journal of Physiology, Pharmacy and Pharmacology 5.3 (2015), 200-206. Print. doi:10.5455/njppp.2015.5.0301201517

APA (American Psychological Association) Style

Kolar Bylappa Bhuvana, Narasimhe Gowda Hema, Rajesh T Patil (2015) Prevalence and risk factors for opportunistic infections in HIV patients who developed adverse drug reactions (ADRs) to antiretroviral therapy (ART) in a tertiary-care teaching hospital. National Journal of Physiology, Pharmacy and Pharmacology, 5 (3), 200-206. doi:10.5455/njppp.2015.5.0301201517



Copyright � 2022 National Journal of Physiology, Pharmacy and Pharmacology All Rights Reserved. Subject to change without notice from or liability to National Journal of Physiology, Pharmacy and Pharmacology. For best results, please use Internet Explorer or Google Chrome	Contact Information Publisher publishernjppp@gmail.com Editorial query editornjppp1@gmail.com MOB - 8780040272

Contact Information

How to cite this article